Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Harper

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2006
Vinorelbine: friend or foe?J H P Robertson, A Dixit, A Smith, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulinL D Lewis, L C Burton, P G Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Paclitaxel and cisplatin in ovarian cancerV Torri, P G Harper, N Colombo, et al.
Archives of Pediatrics & Adolescent Medicine|December 31, 1997
A clinic system to improve preschool vaccinations in a low socioeconomic status populationP G Harper, D J Madlon-Kay, M G Luxenberg, et al.
British Journal of Clinical Pharmacology|November 1, 1990
Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolismL D Lewis, D L Fitzgerald, P G Harper, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Pseudomyxoma peritonei: the 'controversial' diseaseE Galani, G M Marx, C B Steer, et al.
Internal Medicine Journal|September 27, 2003
Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow upC S Karapetis, A H Strickland, D Yip, et al.
Investigational New Drugs|April 12, 2000
Matrix metalloproteinase inhibitors: applications in oncologyD Yip, A Ahmad, C S Karapetis, et al.
British Journal of Urology|November 1, 1988
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regimeM H Cullen, P G Harper, C M Woodroffe, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 16, 2006
Vinorelbine: friend or foe?J H P Robertson, A Dixit, A Smith, et al.
Lancet (London, England)|December 7, 1991
Toxicity and reconstitution of recombinant interleukin-2 with albuminD W Miles, S J Longhurst, P G Harper, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulinL D Lewis, L C Burton, P G Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2000
Paclitaxel and cisplatin in ovarian cancerV Torri, P G Harper, N Colombo, et al.
Archives of Pediatrics & Adolescent Medicine|December 31, 1997
A clinic system to improve preschool vaccinations in a low socioeconomic status populationP G Harper, D J Madlon-Kay, M G Luxenberg, et al.
British Journal of Clinical Pharmacology|November 1, 1990
Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolismL D Lewis, D L Fitzgerald, P G Harper, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2003
Pseudomyxoma peritonei: the 'controversial' diseaseE Galani, G M Marx, C B Steer, et al.
Internal Medicine Journal|September 27, 2003
Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single-centre experience with long-term follow upC S Karapetis, A H Strickland, D Yip, et al.
Investigational New Drugs|April 12, 2000
Matrix metalloproteinase inhibitors: applications in oncologyD Yip, A Ahmad, C S Karapetis, et al.
British Journal of Urology|November 1, 1988
Chemotherapy for poor risk germ cell tumours. An independent evaluation of the POMB/ACE regimeM H Cullen, P G Harper, C M Woodroffe, et al.
Pageof 13